Initial clinical trials with a tubless lithotriptor
Autor: | Lawrence S. Ross, L. Paul Sonda, Stewart Lipson |
---|---|
Rok vydání: | 1990 |
Předmět: |
medicine.medical_specialty
Ureteral Calculi business.industry Urology medicine.medical_treatment Proximal ureter Lithotripsy Surgery Clinical trial Food and drug administration Kidney Calculi medicine.anatomical_structure Multicenter study Single site Fragmentation rate medicine Humans business Renal pelvis |
Zdroj: | The Journal of urology. 143(1) |
ISSN: | 0022-5347 |
Popis: | The Medstone 1050 is a new tubless lithotriptor developed in the United States. Under Food and Drug Administration guidelines a human treatment protocol has been developed. The first 50 patients treated at a single site and followed for a minimum of 3 months are presented. All stones treated were 3cm. or less in longest dimension and located in the renal pelvis, calices or proximal ureter. An adequate fragmentation rate of 90% was achieved in this group. There were no significant complications in any patient. A larger multicenter study presently is underway. (J. Urol, 143: 10-12, 1990) |
Databáze: | OpenAIRE |
Externí odkaz: |